TREVENA INC
Pharmaceutical Preparations · 2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305
官方登記資料
0位追蹤者
2007成立於
關於 TREVENA INC
Trevena, Inc. is a clinical stage biopharmaceutical company, headquartered in Chesterbrook, Pennsylvania, USA, and is involved in the discovery and development of G-protein coupled receptors (GPCR) biased ligands. Trevena was founded in 2007 with technology licensed from Duke University, which originated in the labs of company founders Robert Lefkowitz, winner of the 2012 Nobel Prize in Chemistry, and Howard Rockman. Trevena's approach to drug discovery is based on utilizing ligand bias, or functional selectivity, at GPCR targets to produce drugs with improved efficacy and reduced side effect profiles. Trevena was named one of the top 15 US startups of 2008 by Business Week.
Source: Wikipedia
產業Pharmaceutical Preparations
總部2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305
成立時間2007
法律形式C Corporation
狀態營運中
專利10 項專利
METHODS OF TREATING EPILEPSY USING THE SAMEJP2025138744A · 2025
COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAMEJP2023078375A · 2023
關鍵數據
法律資訊
| 法定名稱 | TREVENA INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1429560在 SEC EDGAR 上查看 ↗ |
| EIN | 26-1469215 |
| 產業代碼(SIC) | 2834 |
| 登記地址 | 2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
2870 PEACHTREE ROAD, SUITE 502, ATLANTA, GA 30305
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面